Obesity Drug Deal: Trump Cuts Prices for Patients
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.
Aspen Targets Mounjaro Expansion in Africa Following Approval
Aspen's Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.
Adcock Ingram Delisting After Natco Acquisition
Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
Spar Acquires Aptekor Group in Retail Healthcare Expansion
Spar acquires Aptekor Group to enhance its national pharmacy network and compete in the South African healthcare market.
Adcock Ingram Takeover Gets Green Light from Shareholders
Shareholders have approved the Adcock Ingram takeover by Natco Pharma, marking a new chapter for the pharmaceutical company.
FDA Generic Drug Review Boosts US Drug Manufacturing
The US Food and Drug Administration (FDA) has announced the launch of a new pilot programme. This programme aims to accelerate the review process for generic drugs. Companies research, develop, and manufacture these drugs entirely within the United States…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log...
Lenacapavir Access Under Scrutiny by Health Advocates
Explore the urgent call for lenacapavir access, as advocates seek equitable HIV prevention for all communities worldwide.
Generic HIV Prevention Drug to Cost Just $40 Annually from 2027
Explore the benefits of the generic HIV prevention drug lenacapavir, set to change the landscape of global health by 2027.
Ascendis to Delist from the Johannesburg Stock Exchange
Ascendis to delist from the JSE as part of its strategy to go private, aiming for operational freedom and agility.
Cheaper Weight-Loss Drugs for Global Health Needs
… Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...